This compound is an Fmoc-protected amino acid derivative designed for use in solid-phase peptide synthesis. It features a 2,4-dimethoxybenzyl protecting group on the amino nitrogen, making it suitable for selective deprotection strategies in research-scale peptide assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 166881-42-1
N-Fmoc-N-(2,4,6-trimethoxybenzyl)glycine
pharmaceutical intermediate
Fmoc-L-propargylglycine
pharmaceutical intermediate
3-[[(Acetylamino)methyl]thio]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valine
pharmaceutical intermediate
N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-L-alanine--water (1/1)
pharmaceutical intermediate
Fmoc-Glycine
pharmaceutical intermediate
17b-(tert-Butylcarbamoyl)-4-aza-5a-androsten-3-one
pharmaceutical intermediate
N-Methyl-4-nitrophenethylamine hydrochloride
pharmaceutical intermediate
1H-indole-6-carboxylic acid
pharmaceutical intermediate
2-[(2,4-dimethoxyphenyl)methyl-(9H-fluoren-9-ylmethoxycarbonyl)amino]acetic acid
UIDQSTVPYKMCEY-UHFFFAOYSA-N
COC1=CC(=C(C=C1)CN(CC(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)OC